Tage Honore - 08 Jun 2023 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
Director
Signature
/s/ Tage Honore
Issuer symbol
VNDA
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 16:19:01 UTC
Previous filing
17 Mar 2023
Next filing
21 May 2024
SEC
View on sec.gov

Key filing fact

Tage Honore filed Form 4 for Vanda Pharmaceuticals Inc. (VNDA) on 12 Jun 2023.

Key facts

  • This page summarizes Tage Honore's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 12 Jun 2023, 16:19.

Change

  • Previous filing in this sequence was filed on 17 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

VNDA transaction

Common Stock

Award

Transaction value
$0
Shares
+17,307
Change %
+66%
Price
$0.000000
Shares after
43,715
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

VNDA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+33,960
Change %
Price
$0.000000
Shares after
33,960
Date
08 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
33,960
Exercise price
$6.50
Footnotes
F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
F2 This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .